Vineti Completes $33.5 Million in Series B Financing to Accelerate Patient Access to Cell and Gene Therapies – GlobeNewswire (press release)
FierceBiotech |
Vineti Completes $33.5 Million in Series B Financing to Accelerate Patient Access to Cell and Gene Therapies
GlobeNewswire (press release) Vineti’s configurable, cloud-based software platform improves cell and gene therapy product performance, promotes regulatory compliance, and enables faster, safer, broader access for patients. The platform automates, orchestrates, and simplifies the … Vineti bags $34M to support CAR-T logisticsFierceBiotech |
Newsweek |
Breakthrough CRISPR Gene Editing Trial Set to Begin This Year
Newsweek Biotech company CRISPR Therapeutics is set to treat Europe’s patients with the CRISPR gene-editing tool this year following regulatory approval for trials. Researchers will apply the much-hyped tool to patients with beta thalassaemia, an inherited … Synthetic Molecules Could Improve CRISPRTechnology Networks Inventor, chemist, and CRISPR craftsman: Inside David Liu’s evolution workshopChemical & Engineering News |